EMDR and Depression: Major Depression and Persistent Depression

At a glance

EMDR may reduce depressive symptoms, and there are randomized studies in adults with major depressive disorder. Direct evidence for persistent depressive disorder is much thinner. These are not three interchangeable statements. A responsible explanation separates improvement in depression scores from evidence for treating a particular diagnosed condition. ^{[1] [2] [3]}

Start by distinguishing the terms

“Depression” may refer to a symptom, a cluster of difficulties, or a diagnosed disorder. Major depression and persistent depressive disorder have specific clinical meanings; persistent depression involves a longer-lasting pattern, not merely a bad week or a mild version of someone else's illness. The National Institute of Mental Health describes several depressive disorders and emphasizes assessment and treatment matched to the individual. ^[4]

This matters when interpreting EMDR studies. An investigation in people with PTSD may report lower depression scores after trauma treatment. That finding is valuable, but it does not establish the same result in a group recruited specifically for major depression. Likewise, a small study of long-term depression cannot provide a reliable success rate for everyone diagnosed with persistent depressive disorder.

What the research says

A 2024 meta-analysis by Seok and Kim combined 25 randomized studies involving 1,042 participants and found an overall benefit for depressive symptoms. The samples and treatment settings varied. The result should not be advertised as 25 trials proving EMDR for primary major depression. The correct author credit also matters: this particular review was not written by Carletto. ^[1]

An MDD-specific review by Yan and colleagues included eight randomized trials with 320 participants. It found encouraging symptom results, but important outcomes were supported by low or very-low certainty evidence. Those limitations make a sweeping claim of superiority over other depression treatments inappropriate. ^[2]

The EDEN trial by Ostacoli and colleagues compared EMDR and CBT as additions to antidepressant treatment for recurrent depression. Both groups improved. A difference on a symptom assessment did not establish a consistent remission advantage or show that either psychotherapy should replace medication. The combined-care design is part of the result, not a detail to leave out. ^[5]

For long-term depression, Wood, Ricketts, and Parry reported a small feasibility study. Its design supports further investigation, not a definitive conclusion about persistent depressive disorder. This is a useful example of a promising clinical lead that still needs stronger testing. ^[3]

Why a memory-focused approach might be considered

A clinician may identify painful experiences, losses, shame, or self-blaming meanings that seem relevant to the person's depression. EMDR may then be considered as a way of addressing those experiences within a treatment plan. That is a clinical formulation, not proof that depression is always caused by unprocessed trauma or that a particular memory-based subgroup is guaranteed to benefit most.

Here is a hypothetical illustration. A person repeatedly interprets ordinary setbacks as evidence that they are a failure. A therapist and client may explore whether an earlier humiliating experience remains strongly connected with that reaction. Even if that connection is useful, it does not explain every contributor to the person's depression or remove the need to attend to present circumstances.

The phrase “particularly helpful when trauma is involved” therefore needs care. It can describe why a therapist is considering the approach, but it should not be presented as a proven treatment-selection rule unless a relevant study has actually established that rule. A persuasive story about fit is not the same as evidence that it predicts the best outcome.

What this means for clients

A good question is, “What part of my depression would we be targeting, and how does this fit with the rest of my care?” The answer may include more than memories. Established depression care can involve psychotherapy, medication, or other treatments depending on the person's needs and clinical situation. An EMDR article is not a reason to stop prescribed treatment or delay an assessment. ^[4]

It is also reasonable to ask how progress will be measured. Feeling less distressed about one experience is useful information, but so are energy, interest in activities, functioning, and the overall course of mood symptoms. Our editorial recommendation is to include both the target-specific change and the wider depressive picture in the review.

What clinicians should communicate

Use different wording for different levels of evidence. “There is promising research in MDD” is more defensible than “EMDR is a proven first-line treatment for every depressive disorder.” “A small study explored long-term depression” is more accurate than “EMDR cures dysthymia.” Clinical confidence should not be manufactured by combining unlike studies into one impressive number.

An informed discussion should also make room for prior treatment history, the person's preferences, current risk, and the need for collaboration with other providers. Severe deterioration or urgent safety concerns require a timely clinical response; they should not be reframed as proof that memory processing is proceeding correctly.

A grounded takeaway

There is a meaningful depression research story to tell, but its value depends on precision. EMDR has promising evidence for depressive symptoms and some evidence in primary MDD. Persistent depressive disorder remains a more tentative application. The strongest public-facing message is not that depression is simply hidden trauma. It is that a carefully assessed memory-focused treatment may be one option within a broader, individualized plan.